The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
The company is already marketing the 4 mg and 10 mg strengths
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
This trial is a multi-national, phase 2/3, open-label, randomized, controlled clinical study of utidelone injectable
The group now has 372 approvals and has so far filed over 442* ANDAs since the commencement of the filing process in FY 2003-04.
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
The new range of HDPE bottles is compliant with US FDA, EU regulations and Chinese DMF registration for use in dry pharmaceutical applications
Subscribe To Our Newsletter & Stay Updated
